Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy

Genes and Development

Volumn 17, Issue 19, 2003, Pages 2436-2449

  Amano, Tetsuya ^a   Yamasaki, Satoshi ^a   Yagishita, Naoko ^a   Tsuchimochi, Kaneyuki ^a,c   Shin, Hiroshi ^b   Kawahara, Ko Ichi ^c   Aratani, Satoko ^a   Fujita, Hidetoshi ^a,b   Zhang, Lei ^a   Ikeda, Rie ^a   Fujii, Ryoji ^a   Miura, Naoki ^c   Komiya, Setsuro ^c   Nishioka, Kusuki ^a   Maruyama, Ikuro ^c   Fukamizu, Akiyoshi ^b   Nakajima, Toshihiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; E3 ubiquitin ligase; Rheumatoid arthritis; Synovial cells

Indexed keywords

COLLAGEN; HRD1 PROTEIN; LIGASE; SYNOVIOLIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HYPERPLASIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; ARTHRITIS; ARTHRITIS, RHEUMATOID; ARTHROPATHY, NEUROGENIC; CELL DIVISION; CELLS, CULTURED; CLONING, MOLECULAR; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; GENE LIBRARY; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; UBIQUITIN-PROTEIN LIGASES;

ANIMALIA;

EID: 10744222535     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1096603     Document Type: Article

References (56)

1. Aarvak, T. and Natvig, J.B. 2001. Cell-cell interactions in synovitis: Antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res. 3: 13-17.
2. Aono, H., Fujisawa, K., Hasunuma, T., Marriott, S.J., and Nishioka, K. 1998. Extracellular human T cell leukemia virus type I tax protein stimulates the proliferation of human synovial cells. Arthritis Rheum. 41: 1995-2003.
3. Arend, W.P. 2001. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum. 45: 101-106.
4. Bays, N.W., Gardner, R.G., Seelig, L.P., Joazeiro, C.A., and Hampton, R.Y. 2001. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation. Nat. Cell Biol. 3: 24-29.
5. Bence, N.F., Sampat, R.M., and Kopito, R.R. 2001. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555.
6. Clair, E.W.S. 2002. Infliximab treatment for rheumatic disease: Clinical and radiological efficacy. Ann. Rheum. Dis. 61 (Suppl II): ii67-ii69.
7. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
8. Evan, G.I. and Vousden, K.H. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348.
9. Feldmann, M., Brennan, F.M., and Maini, R.N. 1996. Rheumatoid arthritis. Cell 85: 307-310.
10. Freemont, P.S. 2000. RING for destruction? Curr. Biol. 10: R84-R87.
11. Friedlander, R., Jarosch, E., Urban, J., Volkwein, C., and Sommer, T. 2000. A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat. Cell Biol. 2: 379-384.
12. Frohman, M.A., Dush, M.K., and Martin, G.R. 1988. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. 85: 8998-9002.
13. Goto, M., Sasano, M., Yamanaka, H., Miyasaka, N., Kamatani, N., Inoue, K., Nishioka, K., and Miyamoto, T. 1987. Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J. Clin. Invest. 80: 786-796.
14. 2 spontaneously in long term culture. J. Rheumatol. 17: 1299-1302.
15. Green, G.S. 2000. Etanercept (Enbrel): Update on therapeutic use. Ann. Rheum. Dis. 59 (Suppl I): i46-i49.
16. Hampton, R.Y. 2002. ER-associated degradation in protein quality control and cellular regulation. Curr. Opin. Cell Biol. 14: 476-482.
17. Harris, E.D. 1990. Rheumatoid arthritis. Pathophysiology and implications for therapy. New Engl. J. Med. 322: 1277-1289.
18. Hofbauer, L.C. and Heufelder, A.E. 2001. The role of osteoprotegerin and receptor activator of nuclear factor κB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum. 44: 253-259.
19. Hogan, B., Beddington, R., Constantini, F., and Lacy, E. 1994. Manipulating the mouse embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Hughes, C., Wolos, J.A., Giannini, E.H., and Hirsch, R. 1994. Induction of T helper cell hyporesponsiveness in an experimental model of autoimmunity by using nonmitogenic anti-CD3 monoclonal antibody. J. Immunol. 153: 3319-3325.
21. Imai, Y., Soda, M., and Takahashi, R. 2000. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275: 35661-35664.
22. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., and Takahashi, R. 2001. An unfolded putative transmembrane polypeptide, which can lead endoplasmic reticulum stress, is a substrate of Parkin. Cell 105: 891-902.
23. Iwakura, Y., Tosu, M., Yoshida, E., Takiguchi, M., Sato, K., Kitajima, I., Nishioka, K., Yamamoto, K., Takeda, T., Hatanaka, M., et al. 1991. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253: 1026-1028.
24. Kaneko, M., Tomita, T., Nakase, T., Ohsawa, Y., Seki, H., Takeuchi, E., Takano, H., Shi, K., Takahi, K., Kominami, E., et al. 2001. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology 40: 247-255.
25. Kaneko, M., Ishiguro, M., Niinuma, Y., Uesugi, M., and Nomura, Y. 2002. Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett. 532: 147-152.
26. Kasama, T., Strieter, R.M., Lukacs, N.W., Lincoln, P.M., Burdick, M.D., and Kunkel, S.L. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95; 2868-2876.
27. Kaufman, R.J. 2002. Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. 110: 1389-1398.
28. Kawahara, K., Watanabe, S., Ohshima, T., Soejima, Y., Oishi, T., Aratani, S., Nakata, M., Shibata, M., Inoue, K., Amano, T., et al. 1999. Hypernuclear acetylation in atherosclerotic lesions and activated vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 266: 417-424.
29. King, K.L. and Cidlowski, J.A. 1998. Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 60: 601-617.
30. Kitajima, I., Yamamoto, K., Sato, K., Nakajima, Y., Nakajima, T., Maruyama, I., Osame, M., and Nishioka, K. 1991. Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J. Clin. Invest. 88: 1315-1322.
31. Nakajima, T., Aono, H., Hasunuma, T., Yamamoto, K., Maruyama, I., Nosaka, T., Hatanaka, M., and Nishioka, K. 1993. Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene. J. Clin. Invest. 92: 186-193.
32. Nakajima, T., Aono, H., Hasunuma, T., Yamamoto, K., Shirai, T., Hirohata, K., and Nishioka, K. 1995. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis. Rheum. 38: 485-491.
33. Nishioka, K., Hasunuma, T., Kato, T., Sumida, T., and Kobata, T. 1998. Apoptosis in rheumatoid arthritis: A novel pathway in the regulation of synovial tissue. Arthritis Rheum. 41: 1-9.
34. Niwa, H., Yamamura, K., and Miyazaki, J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199.
35. Ohta, T., Michel, J.J., Schottelius, A.J., and Xiong, Y. 1999. ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell 3: 535-541.
36. Pap, T., Muller-Ladner, U., Gay, R.E., and Gay, S. 2000. Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2: 361-367.
37. Perlman, H., Pagliari, L.J., and Volin, M.V. 2001. Regulation of apoptosis and cell cycle activity in rheumatoid arthritis. Curr Mol Med. 1: 597-608.
38. Pope, R.M. 2002. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat. Rev. Immunol. 2: 527-535.
39. Rehman, Q. and Lane, N.E. 2001. Bone loss: Therapeutic approaches for preventing bone loss in inflammatory arthritis. Arthritis Res. 3: 221-227.
40. Ron, D. 2002. Translational control in the endoplasmic reticulum stress response. J. Clin. Invest. 110: 1383-1388.
41. Rudin, C.M. and Thompson, C.B. 1997. Apoptosis and disease: Regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 48: 267-281.
42. Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T., and Aizawa, S. 1992. Mice develop normally without tenascin. Genes & Dev. 6: 1821-1831.
43. Sasai, M., Saeki, Y., Ohshima, S., Nishioka, K., Mima, T., Tanaka, T., Katada, Y., Yoshizaki, K., Suemura, M., and Kishimoto, T. 1999. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum. 42: 1635-1643.
44. Schett, G., Tohidast-Akrad, M., Steiner, G., and Smolen, J. 2001. The stressed synovium. Arthritis Res. 3: 80-86.
45. Schultz, J., Copley, R.R., Doerks, T., Ponting, C.P., and Bork, P. 2000. SMART: A web-based tool for the study of genetically mobile domains. Nucleic Acids Res. 28: 231-234.
46. Szekanecz, Z. and Koch, A.E. 2001. Update on synovitis. Curr. Rheumatol. Rep. 3: 53-63.
47. Tak, P.P. and Bresnihan, B. 2000. The pathogenesis and prevention of joint damage in rheumatoid arthritis: Advances from synovial biopsy and tissue analysis. Arthritis Rheum. 43: 2619-2633.
48. Tak, P.P. and Firestein, G.S. 2001. NF-κB: A key role in inflammatory diseases. J. Clin. Invest. 107: 7-11.
49. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
50. Tomita, T., Takeuchi, E., Tomita, N., Morishita, R., Kaneko, M., Yamamoto, K., Nakase, T., Seki, H., Kato, K., Kaneda, Y., et al. 1999. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor KB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 42: 2532-2542.
51. Travers, K.J., Patil, C.K., Wodicka, L., Lockhart, D.J., Weissman, J.S., and Walter, P. 2000 Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101: 249-258.
52. Welihinda, A.A., Tirasophon, W., and Kaufman, R.J. 1999. The cellular response to protein misfolding in the endoplasmic reticulum. Gene Expr. 7: 293-300.
53. Yagi, T., Nada, S., Watanabe, N., Tamemoto, H., Kohmura, N., Ikawa, Y., and Aizawa, S. 1993a. A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal. Biochem. 214: 77-86.
54. Yagi, T., Tokunaga, T., Furuta, Y., Nada, S., Yoshida, M., Tsukada, T., Saga, Y., Takeda, N., Ikawa, Y., and Aizawa, S. 1993b. A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214: 70-76.
55. Yamamoto, Y. and Gaynor, R.B. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107: 135-142.
56. Yokoyama, W.N. 1991. Current protocol in immunology (ed. J.E. Coligan, et al.), pp. 2.1.1-2.5.17. John Wiley & Sons, New York, NY.